17692113

Source:http://linkedlifedata.com/resource/pubmed/id/17692113

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0017337, umls-concept:C0023610, umls-concept:C0205419, umls-concept:C0279752, umls-concept:C0681842, umls-concept:C1274040, umls-concept:C1416843, umls-concept:C1516213
pubmed:issue	4
pubmed:dateCreated	2008-1-16
pubmed:abstractText	Breast cancer development and progression are dependent on estrogen activity. In premenopausal women, estrogen production is mainly regulated through the hypothalamic-pituitary-gonadal (HPG) axis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-10841825, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-10866443, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-10904085, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-10926802, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-11172156, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-11208825, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-11861379, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-11927379, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-12168084, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-12633791, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-12679452, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-12888106, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-12955713, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-15181055, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-15528968, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-15613667, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-15755982, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-16464948, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-16476832, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-17036039, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-2186053, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-2982100, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-320223, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-7556872, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-8630946, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-9178813, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-9423247, http://linkedlifedata.com/resource/pubmed/commentcorrection/17692113-9850346
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100927353
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, LH, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status	MEDLINE
pubmed:issn	1465-542X
pubmed:author	pubmed-author:BernsEls M J JEM, pubmed-author:FoekensJohn AJA, pubmed-author:KlijnJan G MJG, pubmed-author:LookMaxime PMP, pubmed-author:PiersmaDjuraD, pubmed-author:PolsHuibert A PHA, pubmed-author:ThemmenAxel P NAP, pubmed-author:UitterlindenAndré GAG
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R51
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:17692113-Adult, pubmed-meshheading:17692113-Antineoplastic Agents, Hormonal, pubmed-meshheading:17692113-Breast Neoplasms, pubmed-meshheading:17692113-Case-Control Studies, pubmed-meshheading:17692113-Disease-Free Survival, pubmed-meshheading:17692113-Female, pubmed-meshheading:17692113-Genotype, pubmed-meshheading:17692113-Gonadotropin-Releasing Hormone, pubmed-meshheading:17692113-Humans, pubmed-meshheading:17692113-Mastectomy, Segmental, pubmed-meshheading:17692113-Middle Aged, pubmed-meshheading:17692113-Polymorphism, Genetic, pubmed-meshheading:17692113-Premenopause, pubmed-meshheading:17692113-Receptors, Estrogen, pubmed-meshheading:17692113-Receptors, LH, pubmed-meshheading:17692113-Retrospective Studies, pubmed-meshheading:17692113-Survival Rate, pubmed-meshheading:17692113-Tamoxifen, pubmed-meshheading:17692113-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients.
pubmed:affiliation	Department of Internal Medicine, Erasmus MC, 3000 CA Rotterdam, The Netherlands.
pubmed:publicationType	Journal Article, Comparative Study